Incidence of Heart Failure Observed in Emergency Departments, Ambulatory Clinics, and Hospitals

Ricky Camplain, Anna Kucharska-Newton, Thomas C. Keyserling, J. Bradley Layton, Laura Loehr, Gerardo Heiss

Producción científica: Articlerevisión exhaustiva

12 Citas (Scopus)

Resumen

Reports on the burden of heart failure (HF) have largely omitted HF diagnosed in outpatient settings. We quantified annual incidence rates ([IR] per 1,000 person years) of HF identified in ambulatory clinics, emergency departments (EDs), and during hospital stays in a national probability sample of Medicare beneficiaries from 2008 to 2014, by age and race/ethnicity. A 20% random sample of Medicare beneficiaries ages ≥65 years with continuous Medicare Parts A, B, and D coverage was used to estimate annual IRs of HF identified using International Classification of Diseases, Ninth Revision, Clinical Modification codes. Of the 681,487 beneficiaries with incident HF from 2008 to 2014, 283,451 (41%) presented in ambulatory clinics, 76,919 (11%) in EDs, and 321,117 (47%) in hospitals. Overall, incidence of HF in ambulatory clinics decreased from 2008 (IR 22.2, 95% confidence interval [CI] 22.0, 22.4) to 2014 (IR 15.0, 95% CI 14.8, 15.1). Similarly, incidence of HF-related ED visits without an admission to the hospital decreased somewhat from 2008 (IR 5.5, 95% CI 5.4, 5.6) to 2012 (IR 4.2, 95% CI 4.1, 4.3) and stabilized from 2013 to 2014. Similar to previous reports, HF hospitalizations, both International Classification of Diseases, Ninth Revision, Clinical Modification code 428.x in the primary and any position, decreased over the study period. More than half of all new cases of HF in Medicare beneficiaries presented in an ambulatory clinic or ED. The overall incidence of HF decreased from 2008 to 2014, regardless of health-care setting. In conclusion, consideration of outpatient HF is warranted to better understand the burden of HF and its temporal trends.

Idioma originalEnglish
Páginas (desde-hasta)1328-1335
Número de páginas8
PublicaciónAmerican Journal of Cardiology
Volumen121
N.º11
DOI
EstadoPublished - jun 1 2018

Nota bibliográfica

Publisher Copyright:
© 2018 Elsevier Inc.

Financiación

The database infrastructure used for this project was funded by the Pharmacoepidemiology Gillings Innovation Lab (PEGIL) for the Population-Based Evaluation of Drug Benefits and Harms in Older US Adults (GIL 200811.0010), the Center for Pharmacoepidemiology, Department of Epidemiology, UNC Gillings School of Global Public Health; the CER Strategic Initiative of UNC's Clinical & Translational Science Award (UL1TR001111); the Cecil G. Sheps Center for Health Services Research, UNC; and the UNC School of Medicine. Sources of Funding: R. Camplain was supported by the National Heart, Lung, and Blood Institute GRS Diversity Supplement ( HHSN268201100007C ).

FinanciadoresNúmero del financiador
Center for Pharmacoepidemiology, Department of Epidemiology
Pharmacoepidemiology Gillings Innovation Lab
Population-Based Evaluation of Drug Benefits and Harms in Older US AdultsGIL 200811.0010
National Heart, Lung, and Blood Institute (NHLBI)HHSN268201100007C
National Heart, Lung, and Blood Institute (NHLBI)
Cecil G. Sheps Center for Health Services Research, University of North Carolina, Chapel Hill
National Center for Advancing Translational Sciences (NCATS)UL1TR001111
National Center for Advancing Translational Sciences (NCATS)
University of North Carolina and North Carolina State University
School of Medicine, University of North Carolina at Chapel Hill

    ASJC Scopus subject areas

    • Cardiology and Cardiovascular Medicine

    Huella

    Profundice en los temas de investigación de 'Incidence of Heart Failure Observed in Emergency Departments, Ambulatory Clinics, and Hospitals'. En conjunto forman una huella única.

    Citar esto